
Please try another search
Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.
Name | Age | Since | Title |
---|---|---|---|
Ning Li | 54 | 2010 | Chairman of the Board |
Chuang Qiu | 46 | 2015 | Director |
Yu Mao | 44 | 2021 | GM & Director |
Kejian Zhang | 69 | 2020 | Independent Director |
Shanwei Zhang | 45 | 2023 | Director |
Junwei Yang | 50 | 2020 | Deputy GM & Director |
Xiaohui Liu | 56 | 2020 | Independent Director |
Zheng Fan | 41 | 2023 | Employee Representative Supervisor |
Kejing Chen | 39 | 2020 | Independent Director |
Ying Zheng | 42 | 2023 | Chairman of the Supervisory Board |
Quan Yu | 51 | 2023 | Employee Representative Supervisory |
Bingjian Dong | 50 | 2023 | Director |
Jianwei Cui | 47 | 2022 | Deputy GM, CFO, Secretary, Accounting Supervisor & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review